These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35182353)

  • 21. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
    Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
    Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
    Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].
    Lin Y; Zhu X; Liu F; Zhao YY; Du J; Yao GQ; Li WX; Jia XJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):449-53. PubMed ID: 21878165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients.
    Normand S; François B; Dardé ML; Bouteille B; Bonnivard M; Preux PM; Gastinne H; Vignon P
    Intensive Care Med; 2005 Nov; 31(11):1508-13. PubMed ID: 16195905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.
    Chow JK; Golan Y; Ruthazer R; Karchmer AW; Carmeli Y; Lichtenberg D; Chawla V; Young J; Hadley S
    Clin Infect Dis; 2008 Apr; 46(8):1206-13. PubMed ID: 18444857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of mortality in non-neutropenic ICU patients with candidaemia.
    Marriott DJ; Playford EG; Chen S; Slavin M; Nguyen Q; Ellis D; Sorrell TC;
    Crit Care; 2009; 13(4):R115. PubMed ID: 19594912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.
    Senn L; Eggimann P; Ksontini R; Pascual A; Demartines N; Bille J; Calandra T; Marchetti O
    Intensive Care Med; 2009 May; 35(5):903-8. PubMed ID: 19172247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?
    Dupont H; Guilbart M; Ntouba A; Perquin M; Petiot S; Regimbeau JM; Chouaki T; Mahjoub Y; Zogheib E
    Crit Care; 2015 Feb; 19(1):60. PubMed ID: 25849844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.
    Bassetti M; Righi E; Ansaldi F; Merelli M; Scarparo C; Antonelli M; Garnacho-Montero J; Diaz-Martin A; Palacios-Garcia I; Luzzati R; Rosin C; Lagunes L; Rello J; Almirante B; Scotton PG; Baldin G; Dimopoulos G; Nucci M; Munoz P; Vena A; Bouza E; de Egea V; Colombo AL; Tascini C; Menichetti F; Tagliaferri E; Brugnaro P; Sanguinetti M; Mesini A; Sganga G; Viscoli C; Tumbarello M
    Intensive Care Med; 2015 Sep; 41(9):1601-10. PubMed ID: 26077063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.
    Yang SP; Chen YY; Hsu HS; Wang FD; Chen LY; Fung CP
    BMC Infect Dis; 2013 Jan; 13():10. PubMed ID: 23298156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
    Rocco TR; Reinert SE; Simms HH
    Arch Surg; 2000 Feb; 135(2):160-5. PubMed ID: 10668874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials.
    Paphitou NI; Ostrosky-Zeichner L; Rex JH
    Med Mycol; 2005 May; 43(3):235-43. PubMed ID: 16010850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of candidemia in intensive care units.
    Bouza E; Muñoz P
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal outcomes of intra-abdominal infection complicated by critical illness.
    Barie PS; Hydo LJ; Eachempati SR
    Surg Infect (Larchmt); 2004; 5(4):365-73. PubMed ID: 15744128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
    Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SC; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC
    Clin Infect Dis; 2016 Dec; 63(11):1463-1469. PubMed ID: 27601224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis.
    Vege SS; Gardner TB; Chari ST; Baron TH; Clain JE; Pearson RK; Petersen BT; Farnell MB; Sarr MG
    Am J Gastroenterol; 2009 Aug; 104(8):2065-70. PubMed ID: 19491825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic impact of Candida colonization and Candida infection in the critically ill patient.
    Olaechea PM; Palomar M; León-Gil C; Alvarez-Lerma F; Jordá R; Nolla-Salas J; León-Regidor MA;
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):323-30. PubMed ID: 15024623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study.
    Leroy G; Lambiotte F; Thévenin D; Lemaire C; Parmentier E; Devos P; Leroy O
    Ann Intensive Care; 2011 Nov; 1(1):50. PubMed ID: 22128895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.
    Sganga G; Wang M; Capparella MR; Tawadrous M; Yan JL; Aram JA; Montravers P
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1849-1856. PubMed ID: 31280481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.